CJC-1295 with DAC is an artificial analog of the Growth Hormone-Releasing Hormone (GHRH 1-29) that has been modified for increased stability and duration of action by means of attaching a Drug Affinity Complex. This DAC modification will enable scientists to examine extended GHRH receptor activation and endocrine responses in laboratory settings. The examination of CJC-1295 […]
CJC-1295 with DAC is an artificial analog of the Growth Hormone-Releasing Hormone (GHRH 1-29) that has been modified for increased stability and duration of action by means of attaching a Drug Affinity Complex. This DAC modification will enable scientists to examine extended GHRH receptor activation and endocrine responses in laboratory settings.
The examination of CJC-1295 with DAC in the laboratory environment allows the exploration of growth hormone secretion, IGF-1 signaling, pituitary function, endocrinology, protein synthesis, metabolism of the skeletal muscles, recovery processes, studies on body composition, and healthy aging models. Laboratory investigations have focused on understanding the effects of extended GHRH receptor activation on the pattern of hormone secretion, metabolic signaling, and regulatory pathways. Unfortunately, there is currently no experimental evidence in relation to this issue, as it is limited only to laboratory and animal experiments.
Whereas pharmaceutical drugs are made for use in humans, the CJC-1295 with DAC that is available from PeptidesX is designed for use in laboratory investigations, analysis and research purposes only. This product cannot be used in human beings nor in animals. The batches of all such products have Certificates of Analysis which provide information regarding the identification and purity of each batch. The researcher should first go through the Certificate of Analysis before conducting any experiment.
All the CJC-1295 with DAC products that come from PeptidesX are only for research purposes only and should not be used in human beings or animals.
β Research Use Only.
All products supplied by PeptidesX are intended strictly for in-vitro laboratory and scientific research. Not for human consumption, medical use, veterinary use, or therapeutic application. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.
| Test | Specification | Result |
| Appearance | White lyophilised powder | β Conforms |
| HPLC Purity | β₯ 98.0% | 99.% β |
| MS Molecular Weight | Expected Β± 0.5 Da | Confirmed β |
| Amino Acid Analysis | Theoretical sequence | Confirmed β |
| Water Content (KF) | β€ 8.0% | 5.4% β |
| Net Peptide Content | β₯ 85.0% | 90.8% β |
| Test | Specification | Result |
| Endotoxin (LAL) | β€ 5 EU/mg | 0.9 EU/mg β |
| Bioburden | β€ 100 CFU/g | <10 CFU/g β |
| Lead (Pb) | β€ 10 ppm | <0.1 ppm β |
| Arsenic (As) | β€ 5 ppm | <0.1 ppm β |
| Mercury (Hg) | β€ 3 ppm | <0.1 ppm β |
| Cadmium (Cd) | β€ 5 ppm | <0.1 ppm β |
The synthetic form of GHRH called CJC-1295 consists of a DAC to prolong its activity time while working in the laboratory.
The Drug Affinity Complex (DAC) is an additional component which increases the biological activity of the peptide due to prolonging its circulatory time. This version of the peptide is used for studying prolonged GHRH receptor activation and other endocrine reactions.
Yes. CJC-1295 with DAC can be ordered at PeptidesX for conducting scientific research within the UK territory. The peptide can be used only for experimental purposes and cannot be applied for human and veterinary use.
Order the desired CJC-1295 with DAC item on the PeptidesX website and proceed to online checkout. Each product will be provided according to the research-use-only condition.
Independent testing of each individual batch is performed. Please check the Certificate of Analysis accompanying the product.
Research is conducted to study CJC-1295 with DAC in relation to the prolonged activation of GHRH receptors, GH production, IGF-1 pathway, endocrine regulation, metabolism, and hormonal functions.
Studies are usually carried out on pituitary function, hormonal signaling, continuous hormone release, metabolism regulation, muscle biology, recovery mechanisms, health aging, and growth factors signaling via laboratory and preclinical models.
CJC-1295 with DAC is provided as a lyophilized research peptide for lab testing. Specifications, purity data, and batch certification are provided on the respective product page.
The product should be stored according to the directions on the label and Certificate of Analysis. The product should be stored under recommended lab conditions avoiding excessive heat, humidity, and multiple changes in temperature.
It has been shown that administration of CJC-1295 with DAC causes growth hormone release after GHRH receptor activation in preclinical experiments. These observations are relevant only for laboratory and animal studies and do not prove any safety or effectiveness of the drug in humans.
Yes. Research is conducted on CJC-1295 with DAC in studies on endocrine physiology, IGF-1 signaling, metabolic regulation, skeletal muscle biology, body composition studies, and healthy aging models.
No. CJC-1295 with DAC is an investigational research peptide which is not approved by PeptidesX as medicine, dietary supplement, or therapy for any health problem.
Not at all. PeptidesX only offers CJC-1295 DAC for experimental purposes in labs. Results from cells and animals can never prove safety, effectiveness, or usability in humans.
There is an option to deliver to the UK that will be presented during the ordering process. The shipping methods along with the cost are shown on our website.
CJC-1295 DAC is meant to be purchased by universities, research laboratories, biotech firms, scientific institutions, and researchers who perform valid lab research.